Cristal Therapeutics, a clinical stage pharmaceutical company developing unique nanomedicines for the treatment of cancer and other…
NIJMEGEN, the Netherlands – The Netherlands – Khondrion, a leading clinical-stage pharmaceutical company focusing on small molecule…
Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that it has agreed…
Cristal Therapeutics, a privately-held life sciences company developing novel nanomedicines against cancer and other diseases, announced the…
Mucosis, a clinical stage biotechnology company using a proprietary technology platform to develop next-generation and needle-free human…
Recent Comments